Abstract:Tea is the most popular beverage in the world, second only to water. Tea contains an infusion of the leaves from the Camellia sinensis plant rich in polyphenolic compounds known as catechins, the most abundant of which is (-)- EGCG. Although tea has been consumed for centuries, it has only recently been studied extensively as a health-promoting beverage that may act to prevent a number of chronic diseases and cancers. The results of several investigations indicate that green tea consumption may be of modest benefit in reducing the plasma concentration of cholesterol and preventing atherosclerosis. Additionally, the cancer-preventive effects of green tea are widely supported by results from epidemiological, cell culture, animal and clinical studies. In vitro cell culture studies show that tea polyphenols potently induce apoptotic cell death and cell cycle arrest in tumor cells but not in their normal cell counterparts. Green tea polyphenols were shown to affect several biological pathways, including growth factor-mediated pathway, the mitogen-activated protein (MAP) kinase-dependent pathway, and ubiquitin/proteasome degradation pathways. Various animal studies have revealed that treatment with green tea inhibits tumor incidence and multiplicity in different organ sites such as skin, lung, liver, stomach, mammary gland and colon. Recently, phase I and II clinical trials have been conducted to explore the anticancer effects of green tea in humans. A major challenge of cancer prevention is to integrate new molecular findings into clinical practice. Therefore, identification of more molecular targets and biomarkers for tea polyphenols is essential for improving the design of green tea trials and will greatly assist in a better understanding of the mechanisms underlying its anti-cancer activity.

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea

Growth Inhibition of Prostate Cancer Cells by Epigallocatechin Gallate in the Presence of Cu<sup>2+</sup>

Distinct Effects of Tea Catechins on 6-Hydroxydopamine-induced Apoptosis in PC12 Cells

Growth Inhibition Of Prostate Cancer Cells By Epigallocatechin Gallate In The Presenceof Cu2+

Green tea and tea polyphenols in cancer prevention.

Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate

EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

Cancer Preventive Mechanisms Of The Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate

Green Tea Catechins: a Fresh Flavor to Anticancer Therapy.

Molecular Targets for Cancer Chemoprevention by (-)-Epigallocatechin Gallate of Green Tea

Tea polyphenols, their biological effects and potential molecular targets.

Cancer Preventive Activities of Tea Polyphenols

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Green Tea Polyphenols As a Natural Tumour Cell Proteasome Inhibitor.

Anticarcinogenic Potentials of Tea Catechins

Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.

Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review

Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives

Epigallocatechin Gallate Inhibits the Growth of Human Lung Cancer by Directly Targeting the EGFR Signaling Pathway.

Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy